CELYSTRA’s Dawnzera Approved in Canada for Hereditary Angioedema CELYSTRA Pharma announced that Health Canada has approved Dawnzera (donidalorsen) to prevent hereditary angioedema (HAE) attacks in adu...
Pfizer and BioNTech Receive Health Canada Authorization for XFG-Adapted Comirnaty Pfizer and BioNTech received Health Canada authorization for their XFG variant-adapted Comirnaty COVID-19 vaccine for ...
Abbott’s Volt PFA System Debuts in Canada Abbott announced the first Canadian use of its Volt Pulsed Field Ablation (PFA) System at McGill University Health Centre in Montreal to treat patients with a...
Minjuvi Gains Accelerated Funding in Ontario for Relapsed/Refractory Follicular Lymphoma Incyte announced that Minjuvi (tafasitamab), in combination with R² (lenalidomide and rituximab), is now funded...
Leqembi Receives Positive Public Reimbursement Recommendation in Canada BioArctic announced that CDA-AMC has issued a final recommendation supporting public reimbursement of Leqembi (lecanemab) for el...
Bayer’s LYNKUET (elinzanetant) receives expanded authorization in Canada for breast cancer-related vasomotor symptoms Bayer Canada announced that Health Canada has expanded the market authorizat...
Jamieson Wellness to be acquired by Kirin in C$2.5 billion transaction Jamieson Wellness announced that it has entered into a definitive agreement to be acquired by Kirin Holdings Company for C$45.75 ...
Health Canada authorizes P-I clinical trial of Moderna’s mRNA vaccine for Bundibugyo Ebola Health Canada has authorized Moderna to initiate a P-I clinical trial of its candidate mRNA vaccine for Ebola...
GSK’s Shingrix prefilled syringe presentation approved in Canada GSK Canada announced that Health Canada has approved a prefilled syringe presentation of Shingrix (Recombinant Zoster Vaccine) fo...
CDA-AMC recommends public reimbursement of LEQEMBI (lecanemab) for early Alzheimer’s disease Eisai Canada announced that Canada’s Drug Agency (CDA-AMC) has issued a positive recommendation...
